Paroxysmal Nocturnal Hemoglobinuria Market Size, Growth, Analysis, Trend, Major Players and Forecast 2027 | Credence Research
The latest market report published by Credence Research, Inc . "The paroxysmal nocturnal hemoglobinuria (PNH) market was valued at $2,341.4 million in 2018 and is expected to reach $6,203.0 million by 2027, with a compounded annual growth rate (CAGR) of 11.7% projected from 2019 to 2027.". Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and life-threatening blood disorder characterized by the destruction of red blood cells. It results from a genetic mutation leading to an absence or reduction of protective proteins on the surface of red blood cells, making them vulnerable to complement attack. Patients suffering from PNH often experience symptoms such as fatigue, abdominal pain, difficulty swallowing, and blood clots. The condition can also lead to complications like kidney disease and life-threatening blood clots. Market Dynamics The PNH market has witnessed a considerable shift in recent years. Rising awareness about rare diseases, increased diagnosis rates, an...